BLRX

BioLineRX
BLRX

Overview Fund Activity

20 hedge funds and large institutions have $29.3M invested in BioLineRX in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-5
Holders Change %
-20%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Senvest Management
New York
$9.71M
2
Morgan Stanley
2
Morgan Stanley
New York
$1.46M
3
Millennium Management
3
Millennium Management
New York
$1.55M
4
NCCM
4
Nine Chapters Capital Management
New Jersey
$347K
5
BCA
5
Benchmark Capital Advisors
New York
$194K

Top Sellers

1
BI
1
BVF Inc
California
$0
2
SM
2
Sabby Management
Florida
$0
3
SFM
3
Sphera Funds Management
Israel
$0
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$0
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
KA
26
Kovack Advisors
Florida
– -$30K -24 Closed
UBS Group
27
UBS Group
Switzerland
– -$17K -13 Closed
Citigroup
28
Citigroup
New York
– -$11K -8 Closed
1
2